VALVULAR HEART DISEASE: Edited by Subodh Verma and Bobby YanagawaPredicting the future of TAVR an obituary to open aortic valve replacement?Shreenivas, Satyaa; Kaneko, Tsuyoshib; Tang, Gilbert H.L.cAuthor Information aHeart and Vascular Center and the Lindner Research Center, The Christ Hospital. Cincinnati, Ohio bDivision of Cardiac Surgery, Brigham and Women's Hospital. Boston, Massachusetts cDepartment of Cardiovascular Surgery, Mount Sinai Health System. New York, New York Correspondence to Satya Shreenivas, MD, The Christ Hospital Heart and Vascular Center, The Lindner Research Center, 2123 Auburn Avenue, Suite 424, Cincinnati, OH 45219, USA. Tel: +513 585 1777; fax: +513 585 4858; E-mail: [email protected] Current Opinion in Cardiology: March 2019 - Volume 34 - Issue 2 - p 112-123 doi: 10.1097/HCO.0000000000000609 Buy Metrics Abstract Purpose of review Transcatheter aortic valve replacement (TAVR) has become the cornerstone for aortic valve intervention since the first implantation in 2002. Recent advances with novel devices and introduction into lower risk cohorts have been successful. In this review, we discuss the ongoing limitations to transcatheter aortic valve therapy and whether it will replace surgical aortic valve replacement in the foreseeable future. Recent findings A better understanding of valve durability, high-grade heart block, and stroke post TAVR has led to practice changes that improve patient outcome. Summary Although there has been great progress made in treating severe aortic stenosis with TAVR, there are room for improvements before it becomes the default therapy for all patients. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.